Sangamo Biosciences reported $-47169000 in Net Income for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acceleron Pharma XLRN:US $ -63.52M 0.05M
Alnylam Pharmaceuticals ALNY:US $ -189.56M 10.73M
Amgen AMGN:US $ 464M 1182M
Avrobio Inc AVRO:US $ -31387000 4.49M
Bayer BAYN:GR € -2335M 4424M
Biocryst Pharmaceuticals BCRX:US $ -43.2M 21.09M
Biogen BIIB:US $ 448.5M 38.3M
Biomarin Pharmaceutical BMRN:US $ 12.94M 4.43M
Bluebird Bio BLUE:US $ -241.7M 35.89M
Gilead Sciences GILD:US $ 1522M 207M
GlaxoSmithKline GSK:LN 1395M 322M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
IONIS PHARMACEUT IONS:US $ -80.88M 8.99M
Johnson & Johnson JNJ:US $ 6278M 81M
Karyopharm Therapeutics KPTI:US $ -53582000 3.83M
Merk MRK:US $ 1545M 1634M
Novartis NOVN:VX SF 2896M 837M
Omeros OMER:US $ -28593000 6.5M
Pfizer PFE:US $ 5564M 686M
Sangamo Biosciences SGMO:US $ -47.17M 1.24M
Sarepta Therapeutics SRPT:US $ -81.4M 85.84M
Ultragenyx Pharmaceutical RARE:US $ -122.43M 13.71M
Vertex Pharmaceuticals VRTX:US $ 66.92M 586.21M
Ziopharm Oncology ZIOP:US $ -22.67M 1.12M